Healthcare -
Biotechnology - NASDAQ - US
$ 2.85
-5.94 %
$ 182 M
Market Cap
-2.48
P/E
LRMR - OPERATING INCOME
Operating Income LRMR - Larimar Therapeutics, Inc.
-41.8 M
LAST VALUE
9.03%
2 YEAR CAGR
7.81%
5 YEAR CAGR
-11.72%
10 YEAR CAGR